The Pennant Group (NASDAQ:PNTG – Get Free Report) and Precipio (NASDAQ:PRPO – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.
Analyst Recommendations
This is a summary of current ratings and target prices for The Pennant Group and Precipio, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| The Pennant Group | 0 | 1 | 7 | 0 | 2.88 |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
The Pennant Group presently has a consensus target price of $41.60, suggesting a potential upside of 6.67%. Given The Pennant Group’s stronger consensus rating and higher probable upside, equities research analysts clearly believe The Pennant Group is more favorable than Precipio.
Risk & Volatility
Earnings & Valuation
This table compares The Pennant Group and Precipio”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| The Pennant Group | $947.71 million | 1.44 | $29.58 million | $0.90 | 43.33 |
| Precipio | $24.05 million | 1.76 | -$360,000.00 | ($0.64) | -37.00 |
The Pennant Group has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares The Pennant Group and Precipio’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| The Pennant Group | 2.93% | 10.33% | 4.20% |
| Precipio | -4.47% | -8.49% | -5.75% |
Insider & Institutional Ownership
85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 10.4% of Precipio shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 16.6% of Precipio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
The Pennant Group beats Precipio on 11 of the 14 factors compared between the two stocks.
About The Pennant Group
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.
